KIDS · Orthopediatrics Corp · Executive Compensation

$22.06 +0.50 (+2.32%) At close · Sep 11

Russell 2000 member Rebalance outlook locked

Market Cap

$575.98M

26.11M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
David Bailey	President and Chief Executive Officer	$550,000	—	$2,445,200	—	$322,281	$14,000	$3,331,481
Fred L. Hite	Chief Operating Officer and Chief Financial Officer	$501,000	—	$1,588,617	—	$293,569	$14,000	$2,397,186
Joseph W. Hauser	President of Trauma, Deformity and OPSB	$413,000	—	$1,308,399	—	$239,463	$14,000	$1,974,862
Gregory A. Odle	President of Scoliosis	$368,000	—	$972,427	—	$143,757	$14,000	$1,498,184
Daniel J. Gerritzen	Executive Vice President (Legal), General Counsel, and Secretary	$368,000	—	$972,427	—	$143,757	$12,880	$1,497,064

Fiscal 2024

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
David Bailey	President and Chief Executive Officer	$550,000	—	$2,693,771	—	$402,984	$10,133	$3,656,888
Fred L. Hite	Chief Operating Officer and Chief Financial Officer	$501,000	—	$1,699,136	—	$367,082	$13,800	$2,581,018
Joseph W. Hauser	President of Trauma, Deformity and OPSB	$400,000	—	$1,130,493	—	$195,386	$13,800	$1,739,679
Gregory A. Odle	President of Scoliosis	$368,000	—	$1,040,050	—	$179,755	$13,187	$1,600,992
Daniel J. Gerritzen	Executive Vice President (Legal), General Counsel, and Secretary	$368,000	—	$1,040,050	—	$179,755	$12,153	$1,599,958

Fiscal 2023

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
David Bailey	President and Chief Executive Officer	$500,000	—	$1,843,952	—	$364,688	$13,200	$2,721,840
Fred L. Hite	Chief Operating Officer and Chief Financial Officer	$450,000	—	$1,244,700	—	$328,219	$13,200	$2,036,119
Daniel J. Gerritzen	Executive Vice President (Legal), General Counsel, and Secretary	$353,100	—	$813,909	—	$171,695	$13,200	$1,351,904
Gregory A. Odle	President of Scoliosis	$353,100	—	$813,909	—	$171,695	$13,200	$1,351,904
Joseph W. Hauser	President of Trauma, Deformity and OPSB	$353,100	—	$813,909	—	$171,695	$13,200	$1,351,904

Fiscal 2022

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
David Bailey	President and Chief Executive Officer	$415,000	—	$689,961	—	$161,271	$12,200	$1,278,432
Fred L. Hite	Chief Operating Officer and Chief Financial Officer	$408,000	—	$678,302	—	$158,550	$12,200	$1,257,052
Gregory A. Odle	President of Scoliosis	$340,000	—	$565,282	—	$132,125	$12,200	$1,049,607
Daniel J. Gerritzen	Executive Vice President (Legal), General Counsel, and Secretary	$330,000	—	$548,640	—	$128,239	$12,200	$1,019,079
Joseph W. Hauser	President of Trauma, Deformity and OPSB	$330,000	—	$548,640	—	$128,239	$12,200	$1,019,079

Fiscal 2021

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
David Bailey	President and Chief Executive Officer	$371,000	—	$361,360	—	$162,087	$11,600	$906,047
Fred L. Hite	Chief Operating Officer and Chief Financial Officer	$371,000	—	$361,360	—	$162,087	$11,600	$906,047
Gregory A. Odle	President of Scoliosis	$309,000	—	$300,956	—	$134,999	$11,600	$756,555
Joseph W. Hauser	President of Trauma and Deformity Correction	$300,000	—	$300,003	—	$130,693	$11,600	$742,296
Daniel J. Gerritzen	Executive Vice President (Legal), General Counsel, and Secretary	$300,000	—	$292,175	—	$131,067	$11,500	$734,742

Executive changes

Person	Role	Change	Effective	Filed
Kelly Fischer	member of the Board	Appointed	2025-08-08	2025-08-11
Terry Schlotterback	member of the Board	Retired	2025-08-08	2025-08-11
Daniel (Dan) Gerritzen	Executive Vice President & General Counsel	Appointed	2024-10-15	2024-10-18
Fred Hite	Chief Financial Officer & Chief Operating Officer	Appointed	2024-10-15	2024-10-18

Key facts CIK 1425450 CUSIP 68752L100 13F (30d) 42 filings 42 filers Visit website Investor relations